Verition Fund Management LLC Replimune Group, Inc. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 68,325 shares of REPL stock, worth $798,719. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,325
Previous 16,338
318.2%
Holding current value
$798,719
Previous $133,000
361.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding REPL
# of Institutions
154Shares Held
70MCall Options Held
26.7KPut Options Held
28.6K-
Baker Bros. Advisors LP New York, NY10MShares$117 Million1.2% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.24MShares$108 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA5.56MShares$65 Million3.26% of portfolio
-
Fcpm Iii Services B.V. Naarden, P74.87MShares$56.9 Million6.46% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$55.1 Million0.0% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $576M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...